Vascular effects of flavonoids

Current Medicinal Chemistry

Volumn 23, Issue 1, 2016, Pages 87-102

  Rezende, Bruno Almeida ^a,b   Pereira, Aline Carvalho ^a   Cortes, Steyner F ^a   Lemos, Virginia Soares ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Faculdade Ciências Médicas de Minas Gerais   (Brazil)

Author keywords

Cardiovascular system; Flavonoids; Mechanism; Natural products; Signaling pathway; Vascular effects; Vasorelaxation

Indexed keywords

FLAVONOID; ANTIHYPERTENSIVE AGENT;

ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; DRUG BIOAVAILABILITY; DRUG MECHANISM; FOOD INTAKE; HUMAN; INTESTINE ABSORPTION; LIPID METABOLISM; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; VASODILATATION; ANIMAL; BLOOD VESSEL; CARDIOVASCULAR DISEASES; DRUG EFFECTS;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD VESSELS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; FLAVONOIDS; HUMANS; VASODILATION;

EID: 84959422833     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867323666151111143616     Document Type: Article

References (183)

1. Busch, C.; Burkard, M.; Leischner, C.; Lauer, U.M.; Frank, J.; Venturelli, S. Epigenetic activities of flavonoids in the prevention and treatment of cancer. Clin. Epigenetics, 2015, 7(1), 64.
2. Heiss, C.; Kleinbongard, P.; Dejam, A.; Perre, S.; Schroeter, H.; Sies, H.; Kelm, M. Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. J. Am. Coll. Cardiol., 2005, 46(7), 1276- 1283.
3. Mantena, S.K.; Baliga, M.S.; Katiyar, S.K. Grape seed proanthocyanidins induce apoptosis and inhibit metastasis of highly metastatic breast carcinoma cells. Carcinogenesis, 2006, 27(8), 1682-1691.
4. Fabiani, R.; De Bartolomeo, A.; Rosignoli, P.; Servili, M.; Montedoro, G.F.; Morozzi, G. Cancer chemoprevention by hydroxytyrosol isolated from virgin olive oil through G1 cell cycle arrest and apoptosis. Eur. J. Cancer Prev., 2002, 11(4), 351-358.
5. Fini, L.; Hotchkiss, E.; Fogliano, V.; Graziani, G.; Romano, M.; De Vol, E.B.; Qin, H.; Selgrad, M.; Boland, C.R.; Ricciardiello, L. Chemopreventive properties of pinoresinolrich olive oil involve a selective activation of the ATM-p53 cascade in colon cancer cell lines. Carcinogenesis, 2008, 29(1), 139-146.
6. Corona, G.; Deiana, M.; Incani, A.; Vauzour, D.; Dessi, M.A.; Spencer, J.P. Hydroxytyrosol inhibits the proliferation of human colon adenocarcinoma cells through inhibition of ERK1/2 and cyclin D1. Mol. Nutr. Food Res., 2009, 53(7), 897-903.
7. Wang, W.; Heideman, L.; Chung, C.S.; Pelling, J.C.; Koehler, K.J.; Birt, D.F. Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol. Carcinog., 2000, 28(2), 102-110.
8. Piao, M.; Mori, D.; Satoh, T.; Sugita, Y.; Tokunaga, O. Inhibition of endothelial cell proliferation, in vitro angiogenesis, and the down-regulation of cell adhesion-related genes by genistein. Combined with a cDNA microarray analysis. Endothelium, 2006, 13(4), 249-266.
9. Guo, D.J.; Li, F.; Yu, P.H.; Chan, S.W. Neuroprotective effects of luteolin against apoptosis induced by 6- hydroxydopamine on rat pheochromocytoma PC12 cells. Pharm. Biol., 2013, 51(2), 190-196.
10. Karuppagounder, S.S.; Madathil, S.K.; Pandey, M.; Haobam, R.; Rajamma, U.; Mohanakumar, K.P. Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson's disease in rats. Neuroscience, 2013, 236, 136-148.
11. Zern, T.L.; Wood, R.J.; Greene, C.; West, K.L.; Liu, Y.; Aggarwal, D.; Shachter, N.S.; Fernandez, M.L. Grape polyphenols exert a cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and reducing oxidative stress. J. Nutr., 2005, 135(8), 1911-1917.
12. Jeong, Y.J.; Choi, Y.J.; Kwon, H.M.; Kang, S.W.; Park, H.S.; Lee, M.; Kang, Y.H. Differential inhibition of oxidized LDL-induced apoptosis in human endothelial cells treated with different flavonoids. Br. J. Nutr., 2005, 93(5), 581-591.
13. Fuhrman, B.; Volkova, N.; Coleman, R.; Aviram, M. Grape powder polyphenols attenuate atherosclerosis development in apolipoprotein E deficient (E0) mice and reduce macrophage atherogenicity. J. Nutr., 2005, 135(4), 722-728.
14. Hubbard, G.P.; Wolffram, S.; de Vos, R.; Bovy, A.; Gibbins, J.M.; Lovegrove, J.A. Ingestion of onion soup high in quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in man: A pilot study. Br. J. Nutr., 2006, 96(3), 482-488.
15. Ludwig, A.; Lorenz, M.; Grimbo, N.; Steinle, F.; Meiners, S.; Bartsch, C.; Stangl, K.; Baumann, G.; Stangl, V. The tea flavonoid epigallocatechin-3-gallate reduces cytokineinduced VCAM-1 expression and monocyte adhesion to endothelial cells. Biochem. Biophys. Res. Commun., 2004, 316(3), 659-665.
16. Lemos, V.S.; Freitas, M.R.; Muller, B.; Lino, Y.D.; Queiroga, C.E.; Cortes, S.F. Dioclein, a new nitric oxide- and endothelium-dependent vasodilator flavonoid. Eur. J. Pharmacol., 1999, 386(1), 41-46.
17. Hallund, J.; Bugel, S.; Tholstrup, T.; Ferrari, M.; Talbot, D.; Hall, W.L.; Reimann, M.; Williams, C.M.; Wiinberg, N. Soya isoflavone-enriched cereal bars affect markers of endothelial function in postmenopausal women. Br. J. Nutr., 2006, 95(6), 1120-1126.
18. Cortes, S.F.; Rezende, B.A.; Corriu, C.; Medeiros, I.A.; Teixeira, M.M.; Lopes, M.J.; Lemos, V.S. Pharmacological evidence for the activation of potassium channels as the mechanism involved in the hypotensive and vasorelaxant effect of dioclein in rat small resistance arteries. Br. J. Pharmacol., 2001, 133(6), 849-858.
19. Rezende, B.A.; Cortes, S.F.; De Sousa, F.B.; Lula, I.S.; Schmitt, M.; Sinisterra, R.D.; Lemos, V.S. Complexation with beta-cyclodextrin confers oral activity on the flavonoid dioclein. Int. J. Pharm., 2009, 367(1-2), 133-139.
20. Goncalves, R.L.; Lugnier, C.; Keravis, T.; Lopes, M.J.; Fantini, F.A.; Schmitt, M.; Cortes, S.F.; Lemos, V.S. The flavonoid dioclein is a selective inhibitor of cyclic nucleotide phosphodiesterase type 1 (PDE1) and a cGMPdependent protein kinase (PKG) vasorelaxant in human vascular tissue. Eur. J. Pharmacol., 2009, 620(1-3), 78-83.
21. Almeida, A.P.; Cortes, S.F.; Ferreira, A.J.; Lemos, V.S. Increase on the coronary flow induced by dioclein in isolated rat heart. Life Sci., 2002, 70(10), 1121-1128.
22. Rezende, B.A.; Cortes, S.F.; Lemos, V.S. Mechanisms involved in the vasodilator effect of the flavanol floranol in rat small mesenteric arteries. Planta Med., 2004, 70(5), 465-467.
23. Streppel, M.T.; Ocke, M.C.; Boshuizen, H.C.; Kok, F.J.; Kromhout, D. Long-term wine consumption is related to cardiovascular mortality and life expectancy independently of moderate alcohol intake: The Zutphen Study. J. Epidemiol. Community Health, 2009, 63(7), 534-540.
24. Janszky, I.; Mukamal, K.J.; Ljung, R.; Ahnve, S.; Ahlbom, A.; Hallqvist, J. Chocolate consumption and mortality following a first acute myocardial infarction: The Stockholm Heart Epidemiology Program. J. Intern. Med., 2009, 266(3), 248-257.
25. Bondonno, C.P.; Croft, K.D.; Ward, N.; Considine, M.J.; Hodgson, J.M. Dietary flavonoids and nitrate: effects on nitric oxide and vascular function. Nutr. Rev., 2015, 73(4), 216-235.
26. Salvamani, S.; Gunasekaran, B.; Shaharuddin, N.A.; Ahmad, S.A.; Shukor, M.Y. Antiartherosclerotic effects of plant flavonoids. Biomed. Res. Int., 2014, 2014, 480258.
27. Orhan, I.E.; Nabavi, S.F.; Daglia, M.; Tenore, G.C.; Mansouri, K.; Nabavi, S.M. Naringenin and atherosclerosis: A review of literature. Curr. Pharm. Biotechnol., 2015, 16(3), 245-251.
28. Zanotti, I.; Dall'Asta, M.; Mena, P.; Mele, L.; Bruni, R.; Ray, S.; Del Rio, D. Atheroprotective effects of (poly)phenols: A focus on cell cholesterol metabolism. Food Funct., 2015, 6(1), 13-31.
29. Ross, J.A.; Kasum, C.M. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev. Nutr., 2002, 22, 19-34.
30. Bravo, L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev., 1998, 56(11), 317-333.
31. D'Archivio, M.; Filesi, C.; Di Benedetto, R.; Gargiulo, R.; Giovannini, C.; Masella, R. Polyphenols, dietary sources and bioavailability. Ann. Ist Super Sanita, 2007, 43(4), 348- 361.
32. Rice-Evans, C. Flavonoids and isoflavones: Absorption, metabolism, and bioactivity. Free Radic. Biol. Med., 2004, 36(7), 827-828.
33. Leonarduzzi, G.; Testa, G.; Sottero, B.; Gamba, P.; Poli, G. Design and development of nanovehicle-based delivery systems for preventive or therapeutic supplementation with flavonoids. Curr. Med. Chem., 2010, 17(1), 74-95.
34. Calderone, V.; Chericoni, S.; Martinelli, C.; Testai, L.; Nardi, A.; Morelli, I.; Breschi, M.C.; Martinotti, E. Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels. Naunyn Schmiedebergs Arch. Pharmacol., 2004, 370(4), 290-298.
35. Duarte, J.; Perez Vizcaino, F.; Utrilla, P.; Jimenez, J.; Tamargo, J.; Zarzuelo, A. Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationships. Gen. Pharmacol., 1993, 24(4), 857-862.
36. Ko, W.C.; Shih, C.M.; Lai, Y.H.; Chen, J.H.; Huang, H.L. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships. Biochem. Pharmacol., 2004, 68(10), 2087-2094.
37. Andriambeloson, E.; Magnier, C.; Haan-Archipoff, G.; Lobstein, A.; Anton, R.; Beretz, A.; Stoclet, J.C.; Andriantsitohaina, R. Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta. J. Nutr., 1998, 128(12), 2324-2333.
38. Chalopin, M.; Tesse, A.; Martinez, M.C.; Rognan, D.; Arnal, J.F.; Andriantsitohaina, R. Estrogen receptor alpha as a key target of red wine polyphenols action on the endothelium. PLoS One, 2010, 5(1), e8554.
39. Orallo, F.; Alvarez, E.; Basaran, H.; Lugnier, C. Comparative study of the vasorelaxant activity, superoxidescavenging ability and cyclic nucleotide phosphodiesteraseinhibitory effects of hesperetin and hesperidin. Naunyn Schmiedebergs Arch. Pharmacol., 2004, 370(6), 452-463.
40. Orallo, F.; Camina, M.; Alvarez, E.; Basaran, H.; Lugnier, C. Implication of cyclic nucleotide phosphodiesterase inhibition in the vasorelaxant activity of the citrus-fruits flavonoid (+/-)-naringenin. Planta Med., 2005, 71(2), 99-107.
41. Mishra, S.K.; Abbot, S.E.; Choudhury, Z.; Cheng, M.; Khatab, N.; Maycock, N.J.; Zavery, A.; Aaronson, P.I. Endothelium- dependent relaxation of rat aorta and main pulmonary artery by the phytoestrogens genistein and daidzein. Cardiovasc. Res., 2000, 46(3), 539-546.
42. Nevala, R.; Paukku, K.; Korpela, R.; Vapaatalo, H. Calcium- sensitive potassium channel inhibitors antagonize genistein- and daidzein-induced arterial relaxation in vitro. Life Sci., 2001, 69(12), 1407-1417.
43. Zhang, H.T.; Wang, Y.; Deng, X.L.; Dong, M.Q.; Zhao, L.M.; Wang, Y.W. Daidzein relaxes rat cerebral basilar artery via activation of large-conductance Ca2+-activated K+ channels in vascular smooth muscle cells. Eur. J. Pharmacol., 2010, 630(1-3), 100-106.
44. Garcea, G.; Berry, D.P.; Jones, D.J.; Singh, R.; Dennison, A.R.; Farmer, P.B.; Sharma, R.A.; Steward, W.P.; Gescher, A.J. Consumption of the putative chemopreventive agent curcumin by cancer patients: Assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol. Biomarkers Prev., 2005, 14(1), 120-125.
45. Maubach, J.; Bracke, M.E.; Heyerick, A.; Depypere, H.T.; Serreyn, R.F.; Mareel, M.M.; De Keukeleire, D. Quantitation of soy-derived phytoestrogens in human breast tissue and biological fluids by high-performance liquid chromatography. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2003, 784(1), 137-144.
46. Galindo, P.; Gonzalez-Manzano, S.; Zarzuelo, M.J.; Gomez-Guzman, M.; Quintela, A.M.; Gonzalez-Paramas, A.; Santos-Buelga, C.; Perez-Vizcaino, F.; Duarte, J.; Jimenez, R. Different cardiovascular protective effects of quercetin administered orally or intraperitoneally in spontaneously hypertensive rats. Food Funct., 2012, 3(6), 643-650.
47. Lodi, F.; Jimenez, R.; Moreno, L.; Kroon, P.A.; Needs, P.W.; Hughes, D.A.; Santos-Buelga, C.; Gonzalez-Paramas, A.; Cogolludo, A.; Lopez-Sepulveda, R.; Duarte, J.; Perez- Vizcaino, F. Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta. Atherosclerosis, 2009, 204(1), 34-39.
48. Galindo, P.; Rodriguez-Gomez, I.; Gonzalez-Manzano, S.; Duenas, M.; Jimenez, R.; Menendez, C.; Vargas, F.; Tamargo, J.; Santos-Buelga, C.; Perez-Vizcaino, F.; Duarte, J. Glucuronidated quercetin lowers blood pressure in spontaneously hypertensive rats via deconjugation. PLoS One, 2012, 7(3), e32673.
49. Day, A.J.; Williamson, G. Biomarkers for exposure to dietary flavonoids: A review of the current evidence for identification of quercetin glycosides in plasma. Br. J. Nutr., 2001, 86(Suppl1), S105-S110.
50. Natsume, M.; Osakabe, N.; Oyama, M.; Sasaki, M.; Baba, S.; Nakamura, Y.; Osawa, T.; Terao, J. Structures of (-)- epicatechin glucuronide identified from plasma and urine after oral ingestion of (-)-epicatechin: differences between human and rat. Free Radic. Biol. Med., 2003, 34(7), 840- 849.
51. Setchell, K.D.; Faughnan, M.S.; Avades, T.; Zimmer- Nechemias, L.; Brown, N.M.; Wolfe, B.E.; Brashear, W.T.; Desai, P.; Oldfield, M.F.; Botting, N.P.; Cassidy, A. Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women. Am. J. Clin. Nutr., 2003, 77(2), 411-419.
52. Zhang, Y.; Hendrich, S.; Murphy, P.A. Glucuronides are the main isoflavone metabolites in women. J. Nutr., 2003, 133(2), 399-404.
53. Del Rio, D.; Rodriguez-Mateos, A.; Spencer, J.P.; Tognolini, M.; Borges, G.; Crozier, A. Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid. Redox Signal., 2013, 18(14), 1818-1892.
54. Manach, C.; Williamson, G.; Morand, C.; Scalbert, A.; Remesy, C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr., 2005, 81(1Suppl), 230S-242S.
55. Loizzo, M.R.; Said, A.; Tundis, R.; Rashed, K.; Statti, G.A.; Hufner, A.; Menichini, F. Inhibition of angiotensin converting enzyme (ACE) by flavonoids isolated from Ailanthus excelsa (Roxb) (Simaroubaceae). Phytother. Res., 2007, 21(1), 32-36.
56. Guerrero, L.; Castillo, J.; Quinones, M.; Garcia-Vallve, S.; Arola, L.; Pujadas, G.; Muguerza, B. Inhibition of angiotensin- converting enzyme activity by flavonoids: structureactivity relationship studies. PLoS One, 2012, 7(11), e49493.
57. Clifford M.N.; Brown, J. E. Dietry flavonoids and healthbroadening the perspectives In: Flavonoids: Chemistry, Biochemistry and Applications. Andersen; O. M., Markham; Eds.; CRC Press, Boca Raton, FL, 2006; pp. 320-370.
58. In World Health Organization: Geneva, Switzerland, 2008.
59. Roger, V.L.; Go, A.S.; Lloyd-Jones, D.M.; Adams, R.J.; Berry, J.D.; Brown, T.M.; Carnethon, M.R.; Dai, S.; de Si mone, G.; Ford, E.S.; Fox, C.S.; Fullerton, H.J.; Gillespie, C.; Greenlund, K.J.; Hailpern, S.M.; Heit, J.A.; Ho, P.M.; Howard, V.J.; Kissela, B.M.; Kittner, S.J.; Lackland, D.T.; Lichtman, J.H.; Lisabeth, L.D.; Makuc, D.M.; Marcus, G.M.; Marelli, A.; Matchar, D.B.; McDermott, M.M.; Meigs, J.B.; Moy, C.S.; Mozaffarian, D.; Mussolino, M.E.; Nichol, G.; Paynter, N.P.; Rosamond, W.D.; Sorlie, P.D.; Stafford, R.S.; Turan, T.N.; Turner, M.B.; Wong, N.D.; Wylie-Rosett, J.; Subcommittee, A.H.A.S.C.a.S.S. Heart disease and stroke statistics-2011 update: A report from the American Heart Association. Circulation, 2011, 123(4), e18-e209.
60. Allender, S.; Scarborough, P.; Peto, V.; Rayner, M. European CVD statistics 2008, British Heart Foundation, 2008.
61. Dauchet, L.; Amouyel, P.; Dallongeville, J. Fruit and vegetable consumption and risk of stroke: A meta-analysis of cohort studies. Neurology, 2005, 65(8), 1193-1197.
62. Hu, F.B.; Willett, W.C. Optimal diets for prevention of coronary heart disease. JAMA, 2002, 288(20), 2569-2578.
63. Mink, P.J.; Scrafford, C.G.; Barraj, L.M.; Harnack, L.; Hong, C.P.; Nettleton, J.A.; Jacobs, D.R. Flavonoid intake and cardiovascular disease mortality: A prospective study in postmenopausal women. Am. J. Clin. Nutr., 2007, 85(3), 895-909.
64. Bjelakovic, G.; Nikolova, D.; Gluud, L.L.; Simonetti, R.G.; Gluud, C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA, 2007, 297(8), 842- 857.
65. Vivekananthan, D.P.; Penn, M.S.; Sapp, S.K.; Hsu, A.; Topol, E.J. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet, 2003, 361(9374), 2017-2023.
66. Collins, A.R. Assays for oxidative stress and antioxidant status: Applications to research into the biological effectiveness of polyphenols. Am. J. Clin. Nutr., 2005, 81(1Suppl), 261S-267S.
67. Larsson, S.C.; Mannisto, S.; Virtanen, M.J.; Kontto, J.; Albanes, D.; Virtamo, J. Coffee and tea consumption and risk of stroke subtypes in male smokers. Stroke, 2008, 39(6), 1681-1687.
68. Schini-Kerth, V.B.; Auger, C.; Kim, J.H.; Etienne-Selloum, N.; Chataigneau, T. Nutritional improvement of the endothelial control of vascular tone by polyphenols: role of NO and EDHF. Pflugers Arch., 2010, 459(6), 853-862.
69. Sun, G.B.; Qin, M.; Ye, J.X.; Pan, R.L.; Meng, X.B.; Wang, M.; Luo, Y.; Li, Z.Y.; Wang, H.W.; Sun, X.B. Inhibitory effects of myricitrin on oxidative stress-induced endothelial damage and early atherosclerosis in ApoE-/- mice. Toxicol. Appl. Pharmacol., 2013, 271(1), 114-126.
70. Lapointe, A.; Couillard, C.; Lemieux, S. Effects of dietary factors on oxidation of low-density lipoprotein particles. J. Nutr. Biochem., 2006, 17(10), 645-658.
71. Crespo, I.; Garcia-Mediavilla, M.V.; Gutierrez, B.; Sanchez-Campos, S.; Tunon, M.J.; Gonzalez-Gallego, J. A comparison of the effects of kaempferol and quercetin on cytokine-induced pro-inflammatory status of cultured human endothelial cells. Br. J. Nutr., 2008, 100(5), 968-976.
72. Bordeaux, B.; Yanek, L.R.; Moy, T.F.; White, L.W.; Becker, L.C.; Faraday, N.; Becker, D.M. Casual chocolate consumption and inhibition of platelet function. Prev. Cardiol., 2007, 10(4), 175-180.
73. Flammer, A.J.; Hermann, F.; Sudano, I.; Spieker, L.; Hermann, M.; Cooper, K.A.; Serafini, M.; Luscher, T.F.; Ruschitzka, F.; Noll, G.; Corti, R. Dark chocolate improves coronary vasomotion and reduces platelet reactivity. Circulation, 2007, 116(21), 2376-2382.
74. Linden, M.D.; Jackson, D.E. Platelets: pleiotropic roles in atherogenesis and atherothrombosis. Int. J. Biochem. Cell Biol., 2010, 42(11), 1762-1766.
75. Ndiaye, M.; Chataigneau, T.; Andriantsitohaina, R.; Stoclet, J.C.; Schini-Kerth, V.B. Red wine polyphenols cause endothelium- dependent EDHF-mediated relaxations in porcine coronary arteries via a redox-sensitive mechanism. Biochem. Biophys. Res. Commun., 2003, 310(2), 371-377.
76. Ndiaye, M.; Chataigneau, T.; Chataigneau, M.; Schini- Kerth, V.B. Red wine polyphenols induce EDHF-mediated relaxations in porcine coronary arteries through the redoxsensitive activation of the PI3-kinase/Akt pathway. Br. J. Pharmacol., 2004, 142(7), 1131-1136.
77. Nishida, S.; Satoh, H. Role of gap junction involved with endothelium-derived hyperpolarizing factor for the quercetin- induced vasodilatation in rat mesenteric artery. Life Sci., 2013, 92(13), 752-756.
78. Taubert, D.; Roesen, R.; Lehmann, C.; Jung, N.; Schomig, E. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: A randomized controlled trial. JAMA, 2007, 298(1), 49-60.
79. Grassi, D.; Necozione, S.; Lippi, C.; Croce, G.; Valeri, L.; Pasqualetti, P.; Desideri, G.; Blumberg, J.B.; Ferri, C. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension, 2005, 46(2), 398-405.
80. Litterio, M.C.; Jaggers, G.; Sagdicoglu Celep, G.; Adamo, A.M.; Costa, M.A.; Oteiza, P.I.; Fraga, C.G.; Galleano, M. Blood pressure-lowering effect of dietary (-)-epicatechin administration in L-NAME-treated rats is associated with restored nitric oxide levels. Free Radic. Biol. Med., 2012, 53(10), 1894-1902.
81. Gomez-Guzman, M.; Jimenez, R.; Sanchez, M.; Zarzuelo, M.J.; Galindo, P.; Quintela, A.M.; Lopez-Sepulveda, R.; Romero, M.; Tamargo, J.; Vargas, F.; Perez-Vizcaino, F.; Duarte, J. Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin- 1 and NADPH oxidase activity in DOCA-salt hypertension. Free Radic. Biol. Med., 2012, 52(1), 70-79.
82. Ellinger, S.; Reusch, A.; Stehle, P.; Helfrich, H.P. Epicatechin ingested via cocoa products reduces blood pressure in humans: A nonlinear regression model with a Bayesian approach. Am. J. Clin. Nutr., 2012, 95(6), 1365-1377.
83. Jia, L.; Liu, X.; Bai, Y.Y.; Li, S.H.; Sun, K.; He, C.; Hui, R. Short-term effect of cocoa product consumption on lipid profile: A meta-analysis of randomized controlled trials. Am. J. Clin. Nutr., 2010, 92(1), 218-225.
84. Hooper, L.; Kroon, P.A.; Rimm, E.B.; Cohn, J.S.; Harvey, I.; Le Cornu, K.A.; Ryder, J.J.; Hall, W.L.; Cassidy, A. Flavonoids, flavonoid-rich foods, and cardiovascular risk: A meta-analysis of randomized controlled trials. Am. J. Clin. Nutr., 2008, 88(1), 38-50.
85. Averill, M.M.; Bennett, B.J.; Rattazzi, M.; Rodmyre, R.M.; Kirk, E.A.; Schwartz, S.M.; Rosenfeld, M.E. Neither antioxidants nor genistein inhibit the progression of established atherosclerotic lesions in older apoE deficient mice. Atherosclerosis, 2009, 203(1), 82-88.
86. Sirtori, C.R.; Galli, C.; Anderson, J.W.; Arnoldi, A. Nutritional and nutraceutical approaches to dyslipidemia and atherosclerosis prevention: Focus on dietary proteins. Atherosclerosis, 2009, 203(1), 8-17.
87. Sato, M.; Sato, H.; Ogawa, A.; Nomura, R.; Takashima, S.; Bang, H.J.; Matsuoka, H.; Imaizumi, K. Antiatherogenic effect of isoflavones in ovariectomized apolipoprotein edeficient mice. J. Agric. Food Chem., 2007, 55(22), 8967- 8971.
88. Benito, S.; Buxaderas, S.; Mitjavila, M.T. Flavonoid metabolites and susceptibility of rat lipoproteins to oxidation. Am. J. Physiol. Heart Circ. Physiol., 2004, 287(6), H2819- H2824.
89. Auclair, S.; Silberberg, M.; Gueux, E.; Morand, C.; Mazur, A.; Milenkovic, D.; Scalbert, A. Apple polyphenols and fibers attenuate atherosclerosis in apolipoprotein E-deficient mice. J. Agric. Food Chem., 2008, 56(14), 5558-5563.
90. Xia, M.; Ling, W.H.; Ma, J.; Kitts, D.D.; Zawistowski, J. Supplementation of diets with the black rice pigment fraction attenuates atherosclerotic plaque formation in apolipoprotein e deficient mice. J. Nutr., 2003, 133(3), 744-751.
91. Martinez, N.; Casos, K.; Simonetti, P.; Saiz, M.P.; Moreno, J.J.; Mitjavila, M.T. De-alcoholised white and red wines decrease inflammatory markers and NF-κB in atheroma plaques in apoE-deficient mice. Eur. J. Nutr., 2013, 52(2), 737-747.
92. Maeda, K.; Kuzuya, M.; Cheng, X.W.; Asai, T.; Kanda, S.; Tamaya-Mori, N.; Sasaki, T.; Shibata, T.; Iguchi, A. Green tea catechins inhibit the cultured smooth muscle cell invasion through the basement barrier. Atherosclerosis, 2003, 166(1), 23-30.
93. Yousuf, B.; Gul, K.; Wani, A.A.; Singh, P. Health benefits of anthocyanins and their encapsulation for potential use in food systems: A Review. Crit. Rev. Food Sci. Nutr., 2015, [Epub ahead of print].
94. Kris-Etherton, P.M.; Keen, C.L. Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr. Opin. Lipidol., 2002, 13(1), 41-49.
95. Halliwell, B. Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies? Arch. Biochem. Biophys., 2008, 476(2), 107-112.
96. Macakova, K.; Mladenka, P.; Filipsky, T.; Riha, M.; Jahodar, L.; Trejtnar, F.; Bovicelli, P.; Proietti Silvestri, I.; Hrdina, R.; Saso, L. Iron reduction potentiates hydroxyl radical formation only in flavonols. Food Chem., 2012, 135(4), 2584-2592.
97. Kessler, M.; Ubeaud, G.; Jung, L. Anti- and pro-oxidant activity of rutin and quercetin derivatives. J. Pharm. Pharmacol., 2003, 55(1), 131-142.
98. Hollman, P.C.; Cassidy, A.; Comte, B.; Heinonen, M.; Richelle, M.; Richling, E.; Serafini, M.; Scalbert, A.; Sies, H.; Vidry, S. The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established. J. Nutr., 2011, 141(5), 989S-1009S.
99. Tsukamoto, S.; Hirotsu, K.; Kumazoe, M.; Goto, Y.; Sugihara, K.; Suda, T.; Tsurudome, Y.; Suzuki, T.; Yamashita, S.; Kim, Y.; Huang, Y.; Yamada, K.; Tachibana, H. Green tea polyphenol EGCG induces lipid-raft clustering and apoptotic cell death by activating protein kinase Cδ and acid sphingomyelinase through a 67 kDa laminin receptor in multiple myeloma cells. Biochem. J., 2012, 443(2), 525- 534.
100. Agullo, G.; Gamet-Payrastre, L.; Manenti, S.; Viala, C.; Remesy, C.; Chap, H.; Payrastre, B. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3- kinase: A comparison with tyrosine kinase and protein kinase C inhibition. Biochem. Pharmacol., 1997, 53(11), 1649-1657.
101. Mladenka, P.; Zatloukalova, L.; Filipsky, T.; Hrdina, R. Cardiovascular effects of flavonoids are not caused only by direct antioxidant activity. Free Radic. Biol. Med., 2010, 49(6), 963-975.
102. Dower, J.I.; Geleijnse, J.M.; Gijsbers, L.; Zock, P.L.; Kromhout, D.; Hollman, P.C. Effects of the pure flavonoids epicatechin and quercetin on vascular function and cardiometabolic health: A randomized, double-blind, placebocontrolled, crossover trial. Am. J. Clin. Nutr., 2015, 101(5), 914-921.
103. Dower, J.I.; Geleijnse, J.M.; Gijsbers, L.; Schalkwijk, C.; Kromhout, D.; Hollman, P.C. Supplementation of the pure flavonoids epicatechin and quercetin affects some biomarkers of endothelial dysfunction and inflammation in (pre)hypertensive adults: A randomized double-blind, placebo- controlled, crossover trial. J. Nutr., 2015, 145(7), 1459-1463.
104. Beavers, D.P.; Beavers, K.M.; Miller, M.; Stamey, J.; Messina, M.J. Exposure to isoflavone-containing soy products and endothelial function: A Bayesian meta-analysis of randomized controlled trials. Nutr. Metab. Cardiovasc. Dis., 2012, 22(3), 182-191.
105. Wang, X.; Ouyang, Y.Y.; Liu, J.; Zhao, G. Flavonoid intake and risk of CVD: A systematic review and meta-analysis of prospective cohort studies. Br. J. Nutr., 2014, 111(1), 1-11.
106. Onakpoya, I.; Spencer, E.; Heneghan, C.; Thompson, M. The effect of green tea on blood pressure and lipid profile: A systematic review and meta-analysis of randomized clinical trials. Nutr. Metab. Cardiovasc. Dis., 2014, 24(8), 823-836.
107. Khalesi, S.; Sun, J.; Buys, N.; Jamshidi, A.; Nikbakht- Nasrabadi, E.; Khosravi-Boroujeni, H. Green tea catechins and blood pressure: A systematic review and meta-analysis of randomised controlled trials. Eur. J. Nutr., 2014, 53(6), 1299-1311.
108. Barona, J.; Aristizabal, J.C.; Blesso, C.N.; Volek, J.S.; Fernandez, M.L. Grape polyphenols reduce blood pressure and increase flow-mediated vasodilation in men with metabolic syndrome. J. Nutr., 2012, 142(9), 1626-1632.
109. Cassidy, A.; O'Reilly, E.; Kay, C.; Sampson, L.; Franz, M.; Forman, J.P.; Curhan, G.; Rimm, E.B. Habitual intake of flavonoid subclasses and incident hypertension in adults. Am. J. Clin. Nutr., 2011, 93(2), 338-347.
110. Schar, M.Y.; Curtis, P.J.; Hazim, S.; Ostertag, L.M.; Kay, C.D.; Potter, J.F.; Cassidy, A. Orange juice-derived flavanone and phenolic metabolites do not acutely affect cardiovascular risk biomarkers: A randomized, placebocontrolled, crossover trial in men at moderate risk of cardiovascular disease. Am. J. Clin. Nutr., 2015, 101(5), 931- 938.
111. Johnson, S.A.; Figueroa, A.; Navaei, N.; Wong, A.; Kalfon, R.; Ormsbee, L.T.; Feresin, R.G.; Elam, M.L.; Hooshmand, S.; Payton, M.E.; Arjmandi, B.H. Daily blueberry consumption improves blood pressure and arterial stiffness in postmenopausal women with pre- and stage 1-hypertension: A randomized, double-blind, placebo-controlled clinical trial. J. Acad. Nutr. Diet, 2015, 115(3), 369-377.
112. de Jesus Romero-Prado, M.M.; Curiel-Beltran, J.A.; Miramontes-Espino, M.V.; Cardona-Munoz, E.G.; Rios- Arellano, A.; Balam-Salazar, L.B. Dietary flavonoids added to pharmacological antihypertensive therapy are effective in improving blood pressure. Basic Clin. Pharmacol. Toxicol., 2015, 117(1), 57-64.
113. Grassi, D.; Desideri, G.; Necozione, S.; di Giosia, P.; Barnabei, R.; Allegaert, L.; Bernaert, H.; Ferri, C. Cocoa consumption dose-dependently improves flow-mediated dilation and arterial stiffness decreasing blood pressure in healthy individuals. J. Hypertens., 2015, 33(2), 294-303.
114. Perticone, F.; Ceravolo, R.; Pujia, A.; Ventura, G.; Iacopino, S.; Scozzafava, A.; Ferraro, A.; Chello, M.; Mastroroberto, P.; Verdecchia, P.; Schillaci, G. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation, 2001, 104(2), 191-196.
115. Barton, M. Prevention and endothelial therapy of coronary artery disease. Curr. Opin. Pharmacol., 2013, 13(2), 226- 241.
116. Endemann, D.H.; Schiffrin, E.L. Endothelial dysfunction. J. Am. Soc. Nephrol., 2004, 15(8), 1983-1992.
117. Bohm, F.; Pernow, J. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc. Res., 2007, 76(1), 8-18.
118. Bogdan, C. Nitric oxide and the immune response. Nat. Immunol., 2001, 2(10), 907-916.
119. Capettini, L.S.; Cortes, S.F.; Silva, J.F.; Alvarez-Leite, J.I.; Lemos, V.S. Decreased production of neuronal NOSderived hydrogen peroxide contributes to endothelial dysfunction in atherosclerosis. Br. J. Pharmacol., 2011, 164(6), 1738-1748.
120. Levy, A.S.; Chung, J.C.; Kroetsch, J.T.; Rush, J.W. Nitric oxide and coronary vascular endothelium adaptations in hypertension. Vasc. Health Risk Manag., 2009, 5, 1075-1087.
121. Cau, S.B.; Carneiro, F.S.; Tostes, R.C. Differential modulation of nitric oxide synthases in aging: Therapeutic opportunities. Front. Physiol., 2012, 3, 218.
122. Kim, J.H.; Auger, C.; Schini-Kerth, V.B. Activation of eNOS by polyphenol-rich products and polyphenolic compounds. Curr. Pharm. Des., 2014, 20(22), 3521-3529.
123. Perez-Vizcaino, F.; Duarte, J.; Andriantsitohaina, R. Endothelial function and cardiovascular disease: effects of quercetin and wine polyphenols. Free Radic. Res., 2006, 40(10), 1054-1065.
124. Ajay, M.; Gilani, A.U.; Mustafa, M.R. Effects of flavonoids on vascular smooth muscle of the isolated rat thoracic aorta. Life Sci., 2003, 74(5), 603-612.
125. Chen, C.K.; Pace-Asciak, C.R. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen. Pharmacol., 1996, 27(2), 363-366.
126. Pullen, C.; Coulson, F.R.; Fenning, A. Effects of resveratrol and nebivolol on isolated vascular and cardiac tissues from young rats. Adv. Pharmacol. Sci., 2014, 2014, 720386.
127. Galleano, M.; Bernatova, I.; Puzserova, A.; Balis, P.; Sestakova, N.; Pechanova, O.; Fraga, C.G. (-)-Epicatechin reduces blood pressure and improves vasorelaxation in spontaneously hypertensive rats by NO-mediated mechanism. IUBMB Life, 2013, 65(8), 710-715.
128. Kurita, I.; Kim, J.H.; Auger, C.; Kinoshita, Y.; Miyase, T.; Ito, T.; Schini-Kerth, V.B. Hydroxylation of (-)- epigallocatechin-3-O-gallate at 3'', but not 4'', is essential for the PI3-kinase/Akt-dependent phosphorylation of endothelial NO synthase in endothelial cells and relaxation of coronary artery rings. Food Funct., 2013, 4(2), 249-257.
129. Zhang, T.; Niu, C.; Lan, H.; Liu, H.; Jing, H. Vasorelaxant effects of procyanidins on rabbit pulmonic ring in vitro. Zhongguo Zhong Yao Za Zhi, 2009, 34(21), 2813-2816.
130. Fenercioglu, A.K.; Saler, T.; Genc, E.; Sabuncu, H.; Altuntas, Y. The effects of polyphenol-containing antioxidants on oxidative stress and lipid peroxidation in Type 2 diabetes mellitus without complications. J. Endocrinol. Invest., 2010, 33(2), 118-124.
131. Fuhrman, B.; Aviram, M. Flavonoids protect LDL from oxidation and attenuate atherosclerosis. Curr. Opin. Lipidol., 2001, 12(1), 41-48.
132. Kerry, N.L.; Abbey, M. Red wine and fractionated phenolic compounds prepared from red wine inhibit low density lipoprotein oxidation in vitro. Atherosclerosis, 1997, 135(1), 93-102.
133. Cos, P.; Ying, L.; Calomme, M.; Hu, J.P.; Cimanga, K.; Van Poel, B.; Pieters, L.; Vlietinck, A.J.; Vanden Berghe, D. Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers. J. Nat. Prod., 1998, 61(1), 71-76.
134. Chang, W.S.; Lee, Y.J.; Lu, F.J.; Chiang, H.C. Inhibitory effects of flavonoids on xanthine oxidase. Anticancer Res., 1993, 13(6A), 2165-2170.
135. MacKay, C.E.; Knock, G.A. Control of vascular smooth muscle function by Src-family kinases and reactive oxygen species in health and disease. J. Physiol., 2014, 593, 3815- 3828.
136. Jimenez, R.; Lopez-Sepulveda, R.; Romero, M.; Toral, M.; Cogolludo, A.; Perez-Vizcaino, F.; Duarte, J. Quercetin and its metabolites inhibit the membrane NADPH oxidase activity in vascular smooth muscle cells from normotensive and spontaneously hypertensive rats. Food Funct., 2015, 6(2), 409-414.
137. Nussenzweig, S.C.; Verma, S.; Finkel, T. The role of autophagy in vascular biology. Circ. Res., 2015, 116(3), 480- 488.
138. Kolattukudy, P.E.; Niu, J. Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/CCR2 pathway. Circ. Res., 2012, 110(1), 174-189.
139. Kim, H.S.; Montana, V.; Jang, H.J.; Parpura, V.; Kim, J.A. Epigallocatechin gallate (EGCG) stimulates autophagy in vascular endothelial cells: A potential role for reducing lipid accumulation. J. Biol. Chem., 2013, 288(31), 22693-22705.
140. Li, J.; Li, W.; Altura, B.T.; Altura, B.M. Peroxynitriteinduced relaxation in isolated rat aortic rings and mechanisms of action. Toxicol. Appl. Pharmacol., 2005, 209(3), 269-276.
141. Zobali, F.; Cakici, I.; Karasu, C. Effects of peroxynitrite on the reactivity of diabetic rat aorta. Pharmacology, 2001, 63(1), 58-64.
142. Kooy, N.W.; Royall, J.A.; Ye, Y.Z.; Kelly, D.R.; Beckman, J.S. Evidence for in vivo peroxynitrite production in human acute lung injury. Am. J. Respir. Crit. Care Med., 1995, 151(4), 1250-1254.
143. Ibero-Baraibar, I.; Abete, I.; Navas-Carretero, S.; Massis- Zaid, A.; Martinez, J.A.; Zulet, M.A. Oxidised LDL levels decreases after the consumption of ready-to-eat meals supplemented with cocoa extract within a hypocaloric diet. Nutr. Metab. Cardiovasc. Dis., 2014, 24(4), 416-422.
144. Ruijters, E.J.; Weseler, A.R.; Kicken, C.; Haenen, G.R.; Bast, A. The flavanol (-)-epicatechin and its metabolites protect against oxidative stress in primary endothelial cells via a direct antioxidant effect. Eur. J. Pharmacol., 2013, 715(1-3), 147-153.
145. Cruz, M.N.; Agewall, S.; Schenck-Gustafsson, K.; Kublickiene, K. Acute dilatation to phytoestrogens and estrogen receptor subtypes expression in small arteries from women with coronary heart disease. Atherosclerosis, 2008, 196(1), 49-58.
146. Simoncini, T.; Lenzi, E.; Zochling, A.; Gopal, S.; Goglia, L.; Russo, E.; Polak, K.; Casarosa, E.; Jungbauer, A.; Genazzani, A.D.; Genazzani, A.R. Estrogen-like effects of wine extracts on nitric oxide synthesis in human endothelial cells. Maturitas, 2011, 70(2), 169-175.
147. Martin, S.; Andriambeloson, E.; Takeda, K.; Andriantsitohaina, R. Red wine polyphenols increase calcium in bovine aortic endothelial cells: A basis to elucidate signalling pathways leading to nitric oxide production. Br. J. Pharmacol., 2002, 135(6), 1579-1587.
148. Wyatt, A.W.; Steinert, J.R.; Mann, G.E. Modulation of the L-arginine/nitric oxide signalling pathway in vascular endothelial cells. Biochem. Soc. Symp., 2004(71), 143-156.
149. Ndiaye, M.; Chataigneau, M.; Lobysheva, I.; Chataigneau, T.; Schini-Kerth, V.B. Red wine polyphenol-induced, endothelium- dependent NO-mediated relaxation is due to the redox- sensitive PI3-kinase/Akt-dependent phosphorylation of endothelial NO-synthase in the isolated porcine coronary artery. FASEB J., 2005, 19(3), 455-457.
150. Ma, X.; He, D.; Ru, X.; Chen, Y.; Cai, Y.; Bruce, I.C.; Xia, Q.; Yao, X.; Jin, J. Apigenin, a plant-derived flavone, activates transient receptor potential vanilloid 4 cation channel. Br. J. Pharmacol., 2012, 166(1), 349-358.
151. Caulin-Glaser, T.; Garcia-Cardena, G.; Sarrel, P.; Sessa, W.C.; Bender, J.R. 17 beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization. Circ. Res., 1997, 81(5), 885- 892.
152. Dimmeler, S.; Fleming, I.; Fisslthaler, B.; Hermann, C.; Busse, R.; Zeiher, A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature, 1999, 399(6736), 601-605.
153. Michell, B.J.; Griffiths, J.E.; Mitchelhill, K.I.; Rodriguez- Crespo, I.; Tiganis, T.; Bozinovski, S.; de Montellano, P.R.; Kemp, B.E.; Pearson, R.B. The Akt kinase signals directly to endothelial nitric oxide synthase. Curr. Biol., 1999, 9(15), 845-848.
154. Anselm, E.; Chataigneau, M.; Ndiaye, M.; Chataigneau, T.; Schini-Kerth, V.B. Grape juice causes endotheliumdependent relaxation via a redox-sensitive Src- and Aktdependent activation of eNOS. Cardiovasc. Res., 2007, 73(2), 404-413.
155. Kaufeld, A.M.; Pertz, H.H.; Kolodziej, H. 2, 3-cisprocyanidins elicit endothelium-dependent relaxation in porcine coronary arteries via activation of the PI3/Akt kinase signaling pathway. J. Agric. Food Chem., 2013, 61(40), 9609-9616.
156. Kaufeld, A.M.; Pertz, H.H.; Kolodziej, H. A chemically defined 2, 3-trans procyanidin fraction from willow bark causes redox-sensitive endothelium-dependent relaxation in porcine coronary arteries. J. Nat. Prod., 2014, 77(7), 1607- 1614.
157. Madeira, S.V.; Auger, C.; Anselm, E.; Chataigneau, M.; Chataigneau, T.; Soares de Moura, R.; Schini-Kerth, V.B. eNOS activation induced by a polyphenol-rich grape skin extract in porcine coronary arteries. J. Vasc. Res., 2009, 46(5), 406-416.
158. Anselm, E.; Socorro, V.F.; Dal-Ros, S.; Schott, C.; Bronner, C.; Schini-Kerth, V.B. Crataegus special extract WS 1442 causes endothelium-dependent relaxation via a redoxsensitive Src- and Akt-dependent activation of endothelial NO synthase but not via activation of estrogen receptors. J. Cardiovasc. Pharmacol., 2009, 53(3), 253-260.
159. Ullrich, V.; Bachschmid, M. Superoxide as a messenger of endothelial function. Biochem. Biophys. Res. Commun., 2000, 278(1), 1-8.
160. Rubanyi, G.M.; Van Houtte, P.M. Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle. Am. J. Physiol., 1986, 250(5 Pt2), H815-H821.
161. Siow, R.C.; Mann, G.E. Dietary isoflavones and vascular protection: Activation of cellular antioxidant defenses by SERMs or hormesis? Mol. Aspects Med., 2010, 31(6), 468- 477.
162. Fan, Y.F.; Chen, Z.W.; Guo, Y.; Wang, Q.H.; Song, B. Cellular mechanisms underlying Hyperin-induced relaxation of rat basilar artery. Fitoterapia, 2011, 82(4), 626-631.
163. Edwards, G.; Dora, K.A.; Gardener, M.J.; Garland, C.J.; Weston, A.H. K+ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature, 1998, 396(6708), 269-272.
164. Campbell, W.B.; Gebremedhin, D.; Pratt, P.F.; Harder, D.R. Identification of epoxyeicosatrienoic acids as endothelium- derived hyperpolarizing factors. Circ. Res., 1996, 78(3), 415-423.
165. Edwards, G.; Thollon, C.; Gardener, M.J.; Feletou, M.; Vilaine, J.; Vanhoutte, P.M.; Weston, A.H. Role of gap junctions and EETs in endothelium-dependent hyperpolarization of porcine coronary artery. Br. J. Pharmacol., 2000, 129(6), 1145-1154.
166. Matoba, T.; Shimokawa, H.; Nakashima, M.; Hirakawa, Y.; Mukai, Y.; Hirano, K.; Kanaide, H.; Takeshita, A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J. Clin. Invest., 2000, 106(12), 1521-1530.
167. Chen, G.F.; Suzuki, H. Calcium dependency of the endothelium- dependent hyperpolarization in smooth muscle cells of the rabbit carotid artery. J. Physiol., 1990, 421, 521-534.
168. Feletou, M.; Vanhoutte, P.M. The alternative: EDHF. J. Mol. Cell Cardiol., 1999, 31(1), 15-22.
169. Xu, Y.C.; Leung, S.W.; Leung, G.P.; Man, R.Y. Kaempferol enhances endothelium-dependent relaxation in the porcine coronary artery through activation of largeconductance Ca(2+) -activated K(+) channels. Br. J. Pharmacol., 2015, 172(12), 3003-3014.
170. Silva, G.C.; Pereira, A.C.; Rezende, B.A.; da Silva, J.P.; Cruz, J.S.; de Souza, M.e.F.; Gomes, R.A.; Teles, Y.C.; Cortes, S.F.; Lemos, V.S. Mechanism of the antihypertensive and vasorelaxant effects of the flavonoid tiliroside in resistance arteries. Planta Med., 2013, 79(12), 1003-1008.
171. Saponara, S.; Testai, L.; Iozzi, D.; Martinotti, E.; Martelli, A.; Chericoni, S.; Sgaragli, G.; Fusi, F.; Calderone, V. (+/-)-Naringenin as large conductance Ca(2+)-activated K+ (BKCa) channel opener in vascular smooth muscle cells. Br. J. Pharmacol., 2006, 149(8), 1013-1021.
172. Nelson, M.T.; Quayle, J.M. Physiological roles and properties of potassium channels in arterial smooth muscle. Am. J. Physiol., 1995, 268(4 Pt1), 799-822.
173. Liu, Y.; Niu, L.; Cui, L.; Hou, X.; Li, J.; Zhang, X.; Zhang, M. Hesperetin inhibits rat coronary constriction by inhibiting Ca(2+) influx and enhancing voltage-gated K(+) channel currents of the myocytes. Eur. J. Pharmacol., 2014, 735, 193-201.
174. Campos-Toimil, M.; Orallo, F. Effects of (-)-epigallocatechin- 3-gallate in Ca2+ -permeable non-selective cation channels and voltage-operated Ca2+ channels in vascular smooth muscle cells. Life Sci., 2007, 80(23), 2147-2153.
175. Potenza, M.A.; Marasciulo, F.L.; Tarquinio, M.; Tiravanti, E.; Colantuono, G.; Federici, A.; Kim, J.A.; Quon, M.J.; Montagnani, M. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am. J. Physiol. Endocrinol. Metab., 2007, 292(5), E1378-E1387.
176. Fusi, F.; Cavalli, M.; Mulholland, D.; Crouch, N.; Coombes, P.; Dawson, G.; Bova, S.; Sgaragli, G.; Saponara, S. Cardamonin is a bifunctional vasodilator that inhibits Ca(v)1.2 current and stimulates K(Ca)1.1 current in rat tail artery myocytes. J. Pharmacol. Exp. Ther., 2010, 332(2), 531-540.
177. Middleton, E.; Kandaswami, C.; Theoharides, T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev., 2000, 52(4), 673-751.
178. Francis, S.H.; Corbin, J.D. Cyclic nucleotide-dependent protein kinases: intracellular receptors for cAMP and cGMP action. Crit. Rev. Clin. Lab Sci., 1999, 36(4), 275-328.
179. Torres-Piedra, M.; Figueroa, M.; Hernandez-Abreu, O.; Ibarra-Barajas, M.; Navarrete-Vazquez, G.; Estrada-Soto, S. Vasorelaxant effect of flavonoids through calmodulin inhibition: Ex vivo, in vitro, and in silico approaches. Bioorg. Med. Chem., 2011, 19(1), 542-546.
180. Cole, W.C.; Welsh, D.G. Role of myosin light chain kinase and myosin light chain phosphatase in the resistance arterial myogenic response to intravascular pressure. Arch. Biochem. Biophys., 2011, 510(2), 160-173.
181. Jeon, S.B.; Kim, G.; Kim, J.I.; Seok, Y.M.; Kim, S.H.; Suk, K.; Shin, H.M.; Lee, Y.H.; Kim, I.K. Flavone inhibits vascular contraction by decreasing phosphorylation of the myosin phosphatase target subunit. Clin. Exp. Pharmacol. Physiol., 2007, 34(11), 1116-1120.
182. Lopez-Lopez, G.; Moreno, L.; Cogolludo, A.; Galisteo, M.; Ibarra, M.; Duarte, J.; Lodi, F.; Tamargo, J.; Perez- Vizcaino, F. Nitric oxide (NO) scavenging and NO protecting effects of quercetin and their biological significance in vascular smooth muscle. Mol. Pharmacol., 2004, 65(4), 851-859.
183. Kamata, K.; Makino, A.; Kanie, N.; Oda, S.; Matsumoto, T.; Kobayashi, T.; Kikuchi, T.; Nishimura, M.; Honda, T. Effects of anthocyanidin derivative (HK-008) on relaxation in rat perfused mesenterial bed. J. Smooth Muscle Res., 2006, 42(2-3), 75-88.